Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biomarin Pharmaceutical Inc (NASDAQ:BMRN)

95.84
Delayed Data
As of Apr 28
 -0.42 / -0.44%
Today’s Change
73.45
Today|||52-Week Range
102.49
+15.69%
Year-to-Date

Today’s Trading

Previous close96.26
Today’s open96.93
Day’s range95.00 - 97.00
Volume1,240,163
Average volume (3 months)1,117,970
Market cap$16.6B
Dividend yield--
Data as of 4:14pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)-256.07%
Earnings growth (this year)+75.09%
Earnings growth (next 5 years)+127.00%
Revenue growth (last year)+27.18%
P/E ratioNM
Price/Sales12.40
Price/Book5.98

Competitors

 Today’s
change
Today’s
% change
MYLMylan NV-0.37-0.98%
PRGOPerrigo Company PLC-0.07-0.09%
SGENSeattle Genetics Inc+0.04+0.06%
JAZZJazz Pharmaceuticals...-2.73-1.69%
Data as of 4:02pm ET, 04/28/2017

Financials

Next reporting dateMay 4, 2017
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$1.1B
Annual profit (last year)-$630.2M
Net profit margin-56.74%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Jean-Jacques Bienaimé
Chief Financial Officer &
Executive Vice President
Daniel K. Spiegelman
Corporate headquarters
San Rafael, California

Forecasts